-- 日本株は火曜日、長年続いてきた防衛装備品の輸出規制を緩和し、軍艦、ミサイル、その他の兵器の海外販売を容認したことを受け、上昇して取引を終えた。この動きは国内防衛産業への期待感を高めた。 日経平均株価は前日比0.9%高の524.28ポイント上昇し、59,349.17円で引けた。 ウクライナと中東における紛争により米国の兵器生産が逼迫しており、ドナルド・トランプ米大統領の安全保障政策をめぐる不確実性の中で、同盟国が代替供給国を模索する中、日本に供給余地が生まれている。 高市早苗首相は、防衛協力の強化が必要だと述べた。日本政府はこれまで海外販売を制限していた5つの輸出カテゴリーを撤廃した。今後は個々の取引を個別に審査する一方、審査、第三者への移転、紛争地域への販売に関する基本ルールは維持され、国家安全保障上の例外が認められる可能性がある。 企業関連では、霞が関キャピタル(東証:3498)が、三陸沖地震による資産・事業への被害や業績への影響はなかったと発表したことを受け、株価が5%上昇した。 リガク(東証:268A)は、オントイノベーションとの資本・業務提携に合意し、オントイノベーションが27%の株式を取得して筆頭株主となることが発表されたことを受け、株価が22%急騰した。 日産自動車(東証:7201)は、全固体電池の開発が進展し、AI搭載車両やエネルギーソリューションに関する計画を発表したにもかかわらず、株価は2%下落した。
Related Articles
Petro Rabigh Emerges From Loss in Q1; Revenue Grows
Rabigh Refining and Petrochemical (SASE:2380), d/b/a Petro Rabigh, said Sunday it swung back to profit in the first quarter of 2026, while revenue increased year over year.Net profit attributable to shareholders of the issuer for the three months ended March 31 was 1.47 billion Saudi riyals, compared with the attributable loss of 691 million riyals earlier. EPS moved to 0.88 riyal from a loss per share of 0.41 riyal.The Tadawul-listed oil refining and petrochemical company's revenue was 14.85 billion riyals, compared with 11.21 billion riyals a year ago.
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.